comparemela.com

Latest Breaking News On - Christopher missling - Page 1 : comparemela.com

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]

United-states
Sandra-boenisch
Christopher-missling
Soumit-roy
Jones-research
Trademark-office
Food-effect
Receptor-agonist
Frontotemporal-dementia
United-states-patent
Principal-financial-officer
Quality-egg-brands

Anavex stock sinks 30% as lead asset fails in Rett syndrome

Anavex stock sinks 30% as lead asset fails in Rett syndrome
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Walter-kaufmann
Christopher-missling
Anavex-life-science
New-york-city-based

How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News (NASDAQ:AVXL)

How Soon Might Anavex's Alzheimer's Drug Be Approved? The Good/Bad News (NASDAQ:AVXL)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-states
Christopher-missling
Soumit-roy
Anavex-life-sciences
European-agency
Alzheimer-phase
Accelerated-approval
Accelerated-approval-pathway
Disease-dementia-phase
Disease-dementia
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.